Meirik O, Fraser IS, d'Arcangues C. Implantable contraceptives for women. Hum Reprod Update. 2003 Jan-Feb. 9(1):49-59. [QxMD MEDLINE Link].
MedWatch The FDA Safety Information and Adverse Event Reporting Program Accessed 2-13-12. Norplant. [Full Text].
Abraham M, Zhao Q, Peipert JF. Young age, nulliparity, and continuation of long-acting reversible contraceptive methods. Obstet Gynecol. 2015 Oct. 126 (4):823-9. [QxMD MEDLINE Link].
Levine JP, Sinofsky FE, Christ MF. Assessment of Implanon insertion and removal. Contraception. 2008 Nov. 78(5):409-17. [QxMD MEDLINE Link].
Croxatto HB, Urbancsek J, Massai R, Coelingh Bennink H, van Beek A. A multicentre efficacy and safety study of the single contraceptive implant Implanon. Implanon Study Group. Hum Reprod. 1999 Apr. 14(4):976-81. [QxMD MEDLINE Link].
Funk S, Miller MM, Mishell DR Jr, Archer DF, Poindexter A, Schmidt J, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005 May. 71(5):319-26. [QxMD MEDLINE Link].
Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril. 2009 May. 91(5):1646-53. [QxMD MEDLINE Link].
U S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR Recomm Rep. 2010 Jun 18. 59:1-86. [QxMD MEDLINE Link].
Mommers E, Blum GF, Gent TG, Peters KP, Sørdal TS, Marintcheva-Petrova M. Nexplanon, a radiopaque etonogestrel implant in combination with a next-generation applicator: 3-year results of a noncomparative multicenter trial. Am J Obstet Gynecol. 2012 Nov. 207(5):388.e1-6. [QxMD MEDLINE Link].
Wenzl R, VanBeek, A, Schnabel P, Huber J. Pharacokinetics of Etonogestrel Released from the Contraceptive Implant Implanon. Contraception. 1998. 58:283-288. [QxMD MEDLINE Link].
Committee Opinion No. 670 Summary: Immediate Postpartum Long-Acting Reversible Contraception. Obstet Gynecol. 2016 Aug. 128 (2):422-3. [QxMD MEDLINE Link].
Mäkäräinen L, van Beek A, Tuomivaara L, Asplund B, Coelingh Bennink H. Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant. Fertil Steril. 1998 Apr. 69(4):714-21. [QxMD MEDLINE Link].
Higginbotham S. Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091. Contraception. 2009 Dec. 80(6):583-90. [QxMD MEDLINE Link].
Taneepanichskul S, Reinprayoon D, Thaithumyanon P, Praisuwanna P, Tosukhowong P, Dieben T. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception. 2006 Apr. 73(4):368-71. [QxMD MEDLINE Link].
Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sá MF, Vieira CS. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception. 2009 Dec. 80(6):519-26. [QxMD MEDLINE Link].
Committee on Practice Bulletins-Gynecology, Long-Acting Reversible Contraception Work Group. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstet Gynecol. 2017 Nov. 130 (5):e251-e269. [QxMD MEDLINE Link]. [Full Text].
Implanon (etonogestrel implant) [package insert]. Merck. 2006, 2009. Available at [Full Text].
Akturk HK. Locating hormone-releasing contraceptive implants using near-infrared light. Obstet Gynecol. 2021 Mar 1. 137 (3):443-44. [QxMD MEDLINE Link].
Nexplanon, Highlights of Prescribing Information [package insert]. Whitehouse Station, NJ: Merck. 2011. Available at [Full Text].
Shokeir T, Amr M, Abdelshaheed M. The efficacy of Implanon for the treatment of chronic pelvic pain associated with pelvic congestion: 1-year randomized controlled pilot study. Arch Gynecol Obstet. 2009 Sep. 280(3):437-43. [QxMD MEDLINE Link].
Walch K, Unfried G, Huber J, Kurz C, van Trotsenburg M, Pernicka E, et al. Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis--a pilot study. Contraception. 2009 Jan. 79(1):29-34. [QxMD MEDLINE Link].
Croxatto HB. Mechanisms that explain the contraceptive action of progestin implants for women. Contraception. 2002 Jan. 65(1):21-7. [QxMD MEDLINE Link].